Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could muscle loss make chemo more toxic?

NCT ID NCT02734069

Summary

This study aims to understand if a patient's body composition, specifically their muscle mass, affects how much chemotherapy they receive and their risk of severe side effects. Researchers will observe 132 patients with advanced non-small cell lung cancer who are receiving standard chemotherapy. The goal is to gather knowledge to potentially improve how chemotherapy doses are calculated in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto Nacional de Cancerologia

    RECRUITING

    Mexico City, 14080, Mexico

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.